Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline

OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized anima...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Critical care medicine 2005-01, Vol.33 (1), p.203-208
Hauptverfasser: Toung, Thomas J. K, Chang, Yi, Lin, Jonathan, Bhardwaj, Anish
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 208
container_issue 1
container_start_page 203
container_title Critical care medicine
container_volume 33
creator Toung, Thomas J. K
Chang, Yi
Lin, Jonathan
Bhardwaj, Anish
description OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema. DESIGN:Prospective laboratory animal study. SETTING:Research laboratory in a university teaching hospital. SUBJECTS:Adult male Wistar rats (300–450 g, n = 103). INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique. MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%),
doi_str_mv 10.1097/01.CCM.0000150659.15558.23
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_67370748</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>67370748</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</originalsourceid><addsrcrecordid>eNpFkE1vEzEQQC0EoqHwF5CFBLcN4_XaXveGokIrteICZ8vrjMlSxw72rtL-e5wPKb5YM_NmRvMI-cRgyUCrr8CWq9XjEupjAqTQSyaE6Jctf0UWTHBooNX8NVkAaGh4p_kVeVfK34p3QvG35IoJ2XVSwYKM99FltAULHSMNc_xDbVzTIdsa7u2EmfoUQtqPtYLPO8zjFuNkAy1TTk94Q2-9RzfR5OnWxjhOKRwnbF4qO6U4OlpsGCO-J2-8DQU_nP9r8vv77a_VXfPw88f96ttD47huoUGulVJWgvZaaiV1OyBrWYeD5_26V-BbLhX6oV8PDAentZTKaWEFCi-04tfky2nuLqd_M5bJbMfiMAQbMc3FSMUVqK6v4M0JdDmVktGbXT3O5hfDwBxEG2CmijYX0eYo2rS8Nn88b5mHLa4vrWezFfh8BmxxNvhsoxvLhZMdKA0Hrjtx-xSq7fIU5j1ms0Ebps1xNW872bQAAliNmkMG-H-u35bt</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>67370748</pqid></control><display><type>article</type><title>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><creator>Toung, Thomas J. K ; Chang, Yi ; Lin, Jonathan ; Bhardwaj, Anish</creator><creatorcontrib>Toung, Thomas J. K ; Chang, Yi ; Lin, Jonathan ; Bhardwaj, Anish</creatorcontrib><description>OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema. DESIGN:Prospective laboratory animal study. SETTING:Research laboratory in a university teaching hospital. SUBJECTS:Adult male Wistar rats (300–450 g, n = 103). INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique. MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), compared with sham-operated controls (ipsilateral, 79.6 ± 0.9%; contralateral, 79.5 ± 0.9%), as well as in rats that received no fluids (ipsilateral, 84.6 ± 1.8%; contralateral, 80.4 ± 0.9%). Treatment with 5% hypertonic saline (ipsilateral, 83.8 ± 1.0%; contralateral, 79.7 ± 0.6%) and 7.5% hypertonic saline (ipsilateral, 82.3 ± 1.3%; contralateral, 78.6 ± 0.7%) resulted in attenuation of stroke-associated increases in brain water content to a greater extent than mannitol (ipsilateral, 83.6 ± 1.6%; contralateral, 79.1 ± 1.0%). CONCLUSIONS:In a well-characterized animal model of large ischemic stroke, total lung water content increases, which is likely neurogenic in origin. Attenuation of stroke-associated increases in lung and brain water content with continuous infusion of hypertonic saline may have therapeutic implication in the treatment of cerebral and pulmonary edema following ischemic stroke.</description><identifier>ISSN: 0090-3493</identifier><identifier>EISSN: 1530-0293</identifier><identifier>DOI: 10.1097/01.CCM.0000150659.15558.23</identifier><identifier>PMID: 15644670</identifier><identifier>CODEN: CCMDC7</identifier><language>eng</language><publisher>Hagerstown, MD: by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</publisher><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy ; Animals ; Biological and medical sciences ; Blood. Blood coagulation. Reticuloendothelial system ; Brain Edema - physiopathology ; Dominance, Cerebral - physiology ; Extravascular Lung Water - drug effects ; Extravascular Lung Water - metabolism ; Infarction, Middle Cerebral Artery - physiopathology ; Intensive care medicine ; Male ; Mannitol - pharmacology ; Medical sciences ; Neurology ; Pharmacology. Drug treatments ; Pulmonary Edema - physiopathology ; Rats ; Rats, Wistar ; Saline Solution, Hypertonic - pharmacology ; Vascular diseases and vascular malformations of the nervous system ; Water-Electrolyte Balance - drug effects</subject><ispartof>Critical care medicine, 2005-01, Vol.33 (1), p.203-208</ispartof><rights>2005 by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</citedby><cites>FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=16407900$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15644670$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Toung, Thomas J. K</creatorcontrib><creatorcontrib>Chang, Yi</creatorcontrib><creatorcontrib>Lin, Jonathan</creatorcontrib><creatorcontrib>Bhardwaj, Anish</creatorcontrib><title>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</title><title>Critical care medicine</title><addtitle>Crit Care Med</addtitle><description>OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema. DESIGN:Prospective laboratory animal study. SETTING:Research laboratory in a university teaching hospital. SUBJECTS:Adult male Wistar rats (300–450 g, n = 103). INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique. MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), compared with sham-operated controls (ipsilateral, 79.6 ± 0.9%; contralateral, 79.5 ± 0.9%), as well as in rats that received no fluids (ipsilateral, 84.6 ± 1.8%; contralateral, 80.4 ± 0.9%). Treatment with 5% hypertonic saline (ipsilateral, 83.8 ± 1.0%; contralateral, 79.7 ± 0.6%) and 7.5% hypertonic saline (ipsilateral, 82.3 ± 1.3%; contralateral, 78.6 ± 0.7%) resulted in attenuation of stroke-associated increases in brain water content to a greater extent than mannitol (ipsilateral, 83.6 ± 1.6%; contralateral, 79.1 ± 1.0%). CONCLUSIONS:In a well-characterized animal model of large ischemic stroke, total lung water content increases, which is likely neurogenic in origin. Attenuation of stroke-associated increases in lung and brain water content with continuous infusion of hypertonic saline may have therapeutic implication in the treatment of cerebral and pulmonary edema following ischemic stroke.</description><subject>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Blood. Blood coagulation. Reticuloendothelial system</subject><subject>Brain Edema - physiopathology</subject><subject>Dominance, Cerebral - physiology</subject><subject>Extravascular Lung Water - drug effects</subject><subject>Extravascular Lung Water - metabolism</subject><subject>Infarction, Middle Cerebral Artery - physiopathology</subject><subject>Intensive care medicine</subject><subject>Male</subject><subject>Mannitol - pharmacology</subject><subject>Medical sciences</subject><subject>Neurology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Edema - physiopathology</subject><subject>Rats</subject><subject>Rats, Wistar</subject><subject>Saline Solution, Hypertonic - pharmacology</subject><subject>Vascular diseases and vascular malformations of the nervous system</subject><subject>Water-Electrolyte Balance - drug effects</subject><issn>0090-3493</issn><issn>1530-0293</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpFkE1vEzEQQC0EoqHwF5CFBLcN4_XaXveGokIrteICZ8vrjMlSxw72rtL-e5wPKb5YM_NmRvMI-cRgyUCrr8CWq9XjEupjAqTQSyaE6Jctf0UWTHBooNX8NVkAaGh4p_kVeVfK34p3QvG35IoJ2XVSwYKM99FltAULHSMNc_xDbVzTIdsa7u2EmfoUQtqPtYLPO8zjFuNkAy1TTk94Q2-9RzfR5OnWxjhOKRwnbF4qO6U4OlpsGCO-J2-8DQU_nP9r8vv77a_VXfPw88f96ttD47huoUGulVJWgvZaaiV1OyBrWYeD5_26V-BbLhX6oV8PDAentZTKaWEFCi-04tfky2nuLqd_M5bJbMfiMAQbMc3FSMUVqK6v4M0JdDmVktGbXT3O5hfDwBxEG2CmijYX0eYo2rS8Nn88b5mHLa4vrWezFfh8BmxxNvhsoxvLhZMdKA0Hrjtx-xSq7fIU5j1ms0Ebps1xNW872bQAAliNmkMG-H-u35bt</recordid><startdate>200501</startdate><enddate>200501</enddate><creator>Toung, Thomas J. K</creator><creator>Chang, Yi</creator><creator>Lin, Jonathan</creator><creator>Bhardwaj, Anish</creator><general>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</general><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200501</creationdate><title>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</title><author>Toung, Thomas J. K ; Chang, Yi ; Lin, Jonathan ; Bhardwaj, Anish</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3920-e39777a609f9697692be1214ebf38d870f2367efb8db1ebc99667c95a5e5f5973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Blood. Blood coagulation. Reticuloendothelial system</topic><topic>Brain Edema - physiopathology</topic><topic>Dominance, Cerebral - physiology</topic><topic>Extravascular Lung Water - drug effects</topic><topic>Extravascular Lung Water - metabolism</topic><topic>Infarction, Middle Cerebral Artery - physiopathology</topic><topic>Intensive care medicine</topic><topic>Male</topic><topic>Mannitol - pharmacology</topic><topic>Medical sciences</topic><topic>Neurology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Edema - physiopathology</topic><topic>Rats</topic><topic>Rats, Wistar</topic><topic>Saline Solution, Hypertonic - pharmacology</topic><topic>Vascular diseases and vascular malformations of the nervous system</topic><topic>Water-Electrolyte Balance - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Toung, Thomas J. K</creatorcontrib><creatorcontrib>Chang, Yi</creatorcontrib><creatorcontrib>Lin, Jonathan</creatorcontrib><creatorcontrib>Bhardwaj, Anish</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Critical care medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Toung, Thomas J. K</au><au>Chang, Yi</au><au>Lin, Jonathan</au><au>Bhardwaj, Anish</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline</atitle><jtitle>Critical care medicine</jtitle><addtitle>Crit Care Med</addtitle><date>2005-01</date><risdate>2005</risdate><volume>33</volume><issue>1</issue><spage>203</spage><epage>208</epage><pages>203-208</pages><issn>0090-3493</issn><eissn>1530-0293</eissn><coden>CCMDC7</coden><abstract>OBJECTIVE:Pulmonary edema is a serious condition following brain injury of diverse etiologies, including large hemispheric infarctions. We have previously shown that treatment with hypertonic saline attenuates cerebral edema associated with experimental ischemic stroke. In a well-characterized animal model of large ischemic stroke, we tested the hypotheses that lung water increases following cerebral ischemia and determined the effects of osmotherapy with hypertonic saline and mannitol on total lung water, as well as on cerebral edema. DESIGN:Prospective laboratory animal study. SETTING:Research laboratory in a university teaching hospital. SUBJECTS:Adult male Wistar rats (300–450 g, n = 103). INTERVENTIONS:Under controlled conditions of normoxia, normocarbia, and normothermia, spontaneously breathing, halothane-anesthetized (1.0–1.5%) rats were subjected to permanent middle cerebral artery occlusion by the intraluminal occlusion technique. MEASUREMENTS AND MAIN RESULTS:Cerebral perfusion was monitored by laser-Doppler flowmetry over ipsilateral parietal cortex to ensure adequate vascular occlusion. At 6 hrs following middle cerebral artery occlusion, rats were treated in a blinded randomized fashion with no intravenous fluids (n = 24), a continuous intravenous infusion (0.3 mL/hr) of 0.9% saline (n = 21), 20% mannitol (2 g/Kg) (n = 20), 5% hypertonic saline (n = 20), or 7.5% hypertonic saline (n = 18) as a chloride/acetate mixture (50:50) until the end of the experiment. Brains and lungs were harvested, and tissue water content was estimated by comparing wet-to-dry weight ratios of ipsilateral and contralateral cerebral hemispheres at 48 hrs postischemia. Sham-operated rats served as controls (n = 20). Serum osmolality was determined at the end of the experiment in all animals. Lung water content was increased significantly in rats subjected to middle cerebral artery occlusion and treated with no intravenous fluids (76.7 ± 0.7%, 317 ± 7 mOsm/L) (mean ± sd) and saline (76.8 ± 1.2%, 311 ± 10 mOsm/L), compared with sham-operated controls (74.5 ± 0.9%, 302 ± 4 mOsm/L). Treatment with 20% mannitol (74.4 ± 1.2%, 352 ± 15 mOsm/L), 5% hypertonic saline (75.6 ± 1.3%, 339 ± 16 mOsm/L), and 7.5% hypertonic saline (74.9 ± 0.7%, 360 ± 23 mOsm/L) significantly attenuated lung water content. Hemispheric brain water content increased both in the ipsilateral ischemic and contralateral hemispheres treated with saline (ipsilateral, 85.1 ± 1.7%; contralateral, 80.7 ± 0.7%), compared with sham-operated controls (ipsilateral, 79.6 ± 0.9%; contralateral, 79.5 ± 0.9%), as well as in rats that received no fluids (ipsilateral, 84.6 ± 1.8%; contralateral, 80.4 ± 0.9%). Treatment with 5% hypertonic saline (ipsilateral, 83.8 ± 1.0%; contralateral, 79.7 ± 0.6%) and 7.5% hypertonic saline (ipsilateral, 82.3 ± 1.3%; contralateral, 78.6 ± 0.7%) resulted in attenuation of stroke-associated increases in brain water content to a greater extent than mannitol (ipsilateral, 83.6 ± 1.6%; contralateral, 79.1 ± 1.0%). CONCLUSIONS:In a well-characterized animal model of large ischemic stroke, total lung water content increases, which is likely neurogenic in origin. Attenuation of stroke-associated increases in lung and brain water content with continuous infusion of hypertonic saline may have therapeutic implication in the treatment of cerebral and pulmonary edema following ischemic stroke.</abstract><cop>Hagerstown, MD</cop><pub>by the Society of Critical Care Medicine and Lippincott Williams &amp; Wilkins</pub><pmid>15644670</pmid><doi>10.1097/01.CCM.0000150659.15558.23</doi><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0090-3493
ispartof Critical care medicine, 2005-01, Vol.33 (1), p.203-208
issn 0090-3493
1530-0293
language eng
recordid cdi_proquest_miscellaneous_67370748
source MEDLINE; Journals@Ovid Complete
subjects Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Animals
Biological and medical sciences
Blood. Blood coagulation. Reticuloendothelial system
Brain Edema - physiopathology
Dominance, Cerebral - physiology
Extravascular Lung Water - drug effects
Extravascular Lung Water - metabolism
Infarction, Middle Cerebral Artery - physiopathology
Intensive care medicine
Male
Mannitol - pharmacology
Medical sciences
Neurology
Pharmacology. Drug treatments
Pulmonary Edema - physiopathology
Rats
Rats, Wistar
Saline Solution, Hypertonic - pharmacology
Vascular diseases and vascular malformations of the nervous system
Water-Electrolyte Balance - drug effects
title Increases in lung and brain water following experimental stroke: Effect of mannitol and hypertonic saline
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T08%3A57%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Increases%20in%20lung%20and%20brain%20water%20following%20experimental%20stroke:%20Effect%20of%20mannitol%20and%20hypertonic%20saline&rft.jtitle=Critical%20care%20medicine&rft.au=Toung,%20Thomas%20J.%20K&rft.date=2005-01&rft.volume=33&rft.issue=1&rft.spage=203&rft.epage=208&rft.pages=203-208&rft.issn=0090-3493&rft.eissn=1530-0293&rft.coden=CCMDC7&rft_id=info:doi/10.1097/01.CCM.0000150659.15558.23&rft_dat=%3Cproquest_cross%3E67370748%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=67370748&rft_id=info:pmid/15644670&rfr_iscdi=true